8
Oct
2024
Rubicon Research Pvt. Ltd.
Exhibitor at CPHI Milan 2024 stand 16A80, Finished Dosage Formulations
About Us
Categories
-
IN
-
2015On CPHI since
-
3Certificates
-
50 - 99Employees
Company types
Primary activities
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 16A80, Finished Dosage Formulations
Products Featured at CPHI Milan 2024
-
Product Cetirizine Chewable Tablets
Rubicon provides a wide range of cough, cold and anti allergy products which includes Zyrtec, McNeil. It belongs to Lopressor, Novartis brand. Contact us for more information. -
Product Aripiprazole Oral Suspension
Rubicon provides a wide range of central nervous system products which includes aripiprazole ODT. It belongs to Abilify, Otsuka brand. Contact us for more information. -
Product BOUNCE (Nicotine Polacrilex Lozenges)
Nicotine Replacement Therapy. (NRT) for Smoking cessation.
-
Product Desvenlafaxine Succinate ER Tablets
Rubicon provides a wide range of metabolic products which includes paracetamol fastmelt. It belongs to Diamicron, Servier brand. Contact us for more information. -
Product Dorzolamide HCl + Timolol Maleate Eye drops
This product is approved with US FDA .
The product is used for Ocular Hypertension
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance